Jean Claude Osselaer

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

Jean Claude Osselaer, Nathalie Messe, Tor Hervig et al. · Transfusion · 2008 · 97 citations

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use

Jean Claude Osselaer, Chantal Doyen, Laurence Defoin et al. · Transfusion · 2009 · 87 citations

A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–<scp>UVA</scp> photochemical treatment

Folke Knutson, Jean Claude Osselaer, Luca Pierelli et al. · Vox Sanguinis · 2015 · 79 citations · Full text

Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant

Anne Ducart, Édith Collard, Jean Claude Osselaer et al. · Journal of Cardiothoracic and Vascular Anesthesia · 1997 · 37 citations

Thrombosis, Cardiovascular Disease, Cardiopulmonary Bypass +6

Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: A retrospective study

Valentine Minet, Nicolas Bailly, Jonathan Douxfils et al. · Thrombosis Research · 2013 · 27 citations · Full text

Retrospective Study, Biostatistics, Anesthesiology +1